Cargando…
HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469807/ https://www.ncbi.nlm.nih.gov/pubmed/32557883 http://dx.doi.org/10.1111/cas.14536 |
| _version_ | 1783578469430460416 |
|---|---|
| author | Yoneshima, Yasuto Kato, Koji Minami, Haruna Ikeda, Munehiko Watanabe, Hiroyuki Yoshimoto, Goichi Miyamoto, Toshihiro Akashi, Koichi Nakanishi, Yoichi Okamoto, Isamu |
| author_facet | Yoneshima, Yasuto Kato, Koji Minami, Haruna Ikeda, Munehiko Watanabe, Hiroyuki Yoshimoto, Goichi Miyamoto, Toshihiro Akashi, Koichi Nakanishi, Yoichi Okamoto, Isamu |
| author_sort | Yoneshima, Yasuto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7469807 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74698072020-09-09 HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors Yoneshima, Yasuto Kato, Koji Minami, Haruna Ikeda, Munehiko Watanabe, Hiroyuki Yoshimoto, Goichi Miyamoto, Toshihiro Akashi, Koichi Nakanishi, Yoichi Okamoto, Isamu Cancer Sci Letters to the Editor John Wiley and Sons Inc. 2020-07-18 2020-09 /pmc/articles/PMC7469807/ /pubmed/32557883 http://dx.doi.org/10.1111/cas.14536 Text en © 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Yoneshima, Yasuto Kato, Koji Minami, Haruna Ikeda, Munehiko Watanabe, Hiroyuki Yoshimoto, Goichi Miyamoto, Toshihiro Akashi, Koichi Nakanishi, Yoichi Okamoto, Isamu HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors |
| title | HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors |
| title_full | HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors |
| title_fullStr | HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors |
| title_full_unstemmed | HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors |
| title_short | HTLV‐1 seropositive patients with lung cancer treated with PD‐1 inhibitors |
| title_sort | htlv‐1 seropositive patients with lung cancer treated with pd‐1 inhibitors |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469807/ https://www.ncbi.nlm.nih.gov/pubmed/32557883 http://dx.doi.org/10.1111/cas.14536 |
| work_keys_str_mv | AT yoneshimayasuto htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT katokoji htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT minamiharuna htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT ikedamunehiko htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT watanabehiroyuki htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT yoshimotogoichi htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT miyamototoshihiro htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT akashikoichi htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT nakanishiyoichi htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors AT okamotoisamu htlv1seropositivepatientswithlungcancertreatedwithpd1inhibitors |